Comparison of the effect of gonadotropin-releasing hormone agonist dosage in girls with central precocious puberty

Comparison of the effect of gonadotropin-releasing hormone agonist dosage in girls with central precocious puberty

Purpose There are no definite guidelines on the optimal dosage of gonadotropin-releasing hormone (GnRH) agonist for treatment of central precocious puberty (CPP). We compared growth outcomes of GnRH agonist at different dosages in girls with idiopathic CPP to assess the optimal dosage. Methods This...

Full description

Bibliographic Details
Main Authors:	Shinyoung Jang, Su Jin Kim, Myeongseob Lee, Hae In Lee, Ahreum Kwon, Junghwan Suh, Kyungchul Song, Hyun Wook Chae, Ho-Seong Kim
Format:	Article
Language:	English
Published:	Korean Society of Pediatric Endocrinology 2023-02-01
Series:	Annals of Pediatric Endocrinology & Metabolism
Subjects:	gonadotropin-releasing hormone agonist administration and dosage precocious puberty treatment outcome
Online Access:	http://e-apem.org/upload/pdf/apem-2244210-105.pdf

Similar Items

Effect of gonadotropin-releasing hormone agonist treatment on near final height in girls with central precocious puberty and early puberty
by: Eun Hye Yang, et al.
Published: (2023-03-01)

The influence of gonadotropin-releasing hormone agonists on anthropometric change in girls with central precocious puberty
by: Jong Wan Yoon, et al.
Published: (2017-12-01)

Effects of gonadotropin-releasing hormone agonist treatment on final adult height in boys with idiopathic central precocious puberty
by: Ah Young Cho, et al.
Published: (2021-12-01)

Single random measurement of urinary gonadotropin concentration for screening and monitoring girls with central precocious puberty
by: Se Young Lee, et al.
Published: (2021-09-01)

The influence of gonadotropin releasing hormone agonist treatment on the body weight and body mass index in girls with idiopathic precocious puberty and early puberty
by: Sung Woo Kim, et al.
Published: (2017-06-01)

Effect of gonadotropin-releasing hormone agonist therapy on body mass index and growth in girls with idiopathic central precocious puberty
by: Ahmet Anik, et al.
Published: (2015-01-01)

Prevalence of idiopathic scoliosis in girls with central precocious puberty: effect of a gonadotropin-releasing hormone agonist
by: Lindsey Yoojin Chung, et al.
Published: (2020-06-01)

Factors that predict a positive response on gonadotropin-releasing hormone stimulation test for diagnosing central precocious puberty in girls
by: Junghwan Suh, et al.
Published: (2013-12-01)

Age of menarche and near adult height after long-term gonadotropin-releasing hormone agonist treatment in girls with central precocious puberty
by: Joon-Woo Baek, et al.
Published: (2014-03-01)

Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone agonist with or without growth hormone
by: Mo Kyung Jung, et al.
Published: (2014-12-01)

Insulin resistance and bone age advancement in girls with central precocious puberty
by: Jin Ho Hur, et al.
Published: (2017-09-01)

Long-term effects of gonadotropin-releasing hormone analogs in girls with central precocious puberty
by: Eun Young Kim
Published: (2015-01-01)

The different effects of gonadotropin-releasing hormone agonist therapy on body mass index and growth between normal-weight and overweight girls with central precocious puberty
by: Won Jun Yang, et al.
Published: (2017-03-01)

Changes in body mass index in boys with central precocious puberty over 2 years of gonadotropin-releasing hormone agonist therapy
by: Kyung In Lim, et al.
Published: (2020-09-01)

Treatment with Depot Leuprolide Acetate in Girls with Idiopathic Precocious Puberty: What Parameter should be Used in Deciding on the Initial Dose?
by: Doğuş Vurallı, et al.
Published: (2020-03-01)

Adult height in girls with central precocious puberty without gonadotropin-releasing hormone agonist treatment: a retrospective case-control study
by: Hyun Ji Jang, et al.
Published: (2023-11-01)

Management of Central Precocious Puberty in Children with Hypothalamic Hamartoma
by: Junghwan Suh, et al.
Published: (2021-08-01)

Central precocious puberty due to hypothalamic hamartoma in a six-month-old infant girl
by: Narendra Kotwal, et al.
Published: (2012-01-01)

Comparing adult height gain and menarcheal age between girls with central precocious puberty treated with gonadotropin-releasing hormone agonist alone and those treated with combined growth hormone therapy
by: Min Sub Kim, et al.
Published: (2019-06-01)

Bone mineral density and body composition in girls with idiopathic central precocious puberty before and after treatment with a gonadotropin-releasing hormone agonist
by: Sandra B. Alessandri, et al.
Published: (2012-01-01)

The analysis of endocrine disruptors in patients with central precocious puberty
by: Mo Kyung Jung, et al.
Published: (2019-09-01)

Gonadotropin-releasing hormone stimulation test and diagnostic cutoff in precocious puberty: a mini review
by: Siti Nadirah Ab Rahim, et al.
Published: (2020-07-01)

Rapidly Progressive Precocious Puberty With an Elevated Testosterone Level in a 5-Year-Old Boy With a β-Human Chorionic Gonadotropin-Secreting Intracranial Germ Cell Tumor in the Pineal Gland
by: Maria Graciela Parra Villasmil, MD, et al.
Published: (2022-07-01)

The Effect of Gonadotropin-releasing Hormone Analog Treatment on Body Mass Index and Height in Female Patients with Central Precocious Puberty
by: Muammer Büyükinan, et al.
Published: (2019-03-01)

A Testicular Leydig Cell Tumor; An Uncommon Cause of Precocious Puberty: A Case Report With Secondary Central Precocious Puberty
by: Seyede Tahereh Mousavi, et al.
Published: (2023-04-01)

Gonadotropin-releasing hormone analog therapies for children with central precocious puberty in the United States
by: Jadranka Popovic, et al.
Published: (2022-10-01)

Elevated Pre-injection Basal Luteinizing Hormone Concentrations are Common in Girls Treated for Central Precocious Puberty
by: Stefanie Schubert, et al.
Published: (2021-06-01)

The Side Effects of Gonadotropin Releasing Hormone Analog (Diphereline) in Treatment of Idiopathic Central Precocious Puberty
by: Zohreh Karamizadeh, et al.
Published: (2013-01-01)

The Side Effects of Gonadotropin Releasing Hormone Analog (Diphereline) in Treatment of Idiopathic Central Precocious Puberty
by: Zohreh Karamizadeh, et al.
Published: (2013-01-01)

Diagnostic evaluation of central precocious puberty in girls
by: Shu-Nin Yeh, et al.
Published: (2021-03-01)

The value of urinary gonadotropins in the diagnosis of central precocious puberty: a meta-analysis
by: Dan Xu, et al.
Published: (2022-07-01)

Effectiveness of the triptorelin stimulation test compared with the classic gonadotropin-releasing hormone stimulation test in diagnosing central precocious puberty in girls
by: Yu Jin Kim, et al.
Published: (2024-04-01)

Diurnal variation of gonadotropin levels in girls with early stages of puberty
by: Yu Sun Kang, et al.
Published: (2017-09-01)

Clinical data and basal gonadotropins in the diagnosis of central precocious puberty in girls
by: Teodoro Durá-Travé, et al.
Published: (2021-03-01)

Change in body mass index and insulin resistance after 1-year treatment with gonadotropin-releasing hormone agonists in girls with central precocious puberty
by: Jina Park, et al.
Published: (2017-03-01)

Long-term efficacy of a triptorelin 3-month depot in girls with central precocious puberty
by: Kyu Hyun Park, et al.
Published: (2024-06-01)

Different clinical courses of central precocious girls according to their age at presentation and treatment
by: Shin-Ae Yoon, et al.
Published: (2013-03-01)

Myopic Progression in Girls with Gonadotrophin-Releasing Hormone Agonist Treatment for Central Precocious Puberty
by: Seung Ah Chung, et al.
Published: (2021-02-01)

Diagnostic value of urinary luteinizing hormone levels in the monitoring of precocious puberty treatment
by: Özge Yüce, et al.
Published: (2020-03-01)

Body image and depression in girls with idiopathic precocious puberty treated with gonadotropin-releasing hormone analogue
by: Min-Seon Choi, et al.
Published: (2016-09-01)